BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 32526600)

  • 21. Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.
    Khullar OV; Liu Y; Gillespie T; Higgins KA; Ramalingam S; Lipscomb J; Fernandez FG
    J Thorac Oncol; 2015 Nov; 10(11):1625-33. PubMed ID: 26352534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis.
    Yang H; Mei T
    Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35512177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
    Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
    Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
    Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of Lobectomy and Sublobar Resection for Stage I Non-small Cell Lung Cancer With Spread Through Air Spaces.
    Li J; Wang Y; Li J; Cao S; Che G
    Clin Lung Cancer; 2022 May; 23(3):208-213. PubMed ID: 34799251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
    Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
    Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
    Chiang XH; Hsu HH; Hsieh MS; Chang CH; Tsai TM; Liao HC; Tsou KC; Lin MW; Chen JS
    Ann Surg Oncol; 2020 Mar; 27(3):703-715. PubMed ID: 31646453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.
    Tsutani Y; Kagimoto A; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2019 Dec; 49(12):1134-1142. PubMed ID: 31602468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer: A systematic review and meta-analysis of randomized controlled trials.
    Meldola PF; Toth OAS; Schnorrenberger E; Machado PG; Chiarelli GFC; Kracik JLS; de Carvalho CC; Lôbo MM; Gross JL
    Surg Oncol; 2023 Dec; 51():101995. PubMed ID: 37776757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer ≤2 cm.
    Cao J; Xu J; He Z; Yuan P; Huang S; Lv W; Hu J
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):796-805.e4. PubMed ID: 29716729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Segmentectomy Provides Comparable Outcomes to Lobectomy for Stage IA Non-small Cell Lung Cancer with Spread through Air Spaces.
    Ikeda T; Kadota K; Go T; Misaki N; Haba R; Yokomise H
    Semin Thorac Cardiovasc Surg; 2023; 35(1):156-163. PubMed ID: 35149218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
    Kim D; Ferraris VA; Davenport D; Saha S
    South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease.
    Liou DZ; Chan M; Bhandari P; Lui NS; Backhus LM; Shrager JB; Berry MF
    Eur J Cardiothorac Surg; 2022 Oct; 62(5):. PubMed ID: 36063054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphovascular invasion: A non-sized T descriptor for stage IA non-small cell lung cancer.
    Cai JS; Wang X; Yang F; Li Y; Qiu MT
    Thorac Cancer; 2022 Sep; 13(17):2413-2420. PubMed ID: 35670186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.